Argonne researchers have developed a pipeline between ALCF supercomputers and Advanced Photon Source experiments to enable on-demand analysis of the crystal structure of COVID-19 proteins.
Image and text from phys.org
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). The structure was solved by a team including the University of Chicago, the U.S. Department of Energy’s Argonne National Laboratory, Northwestern University Feinberg School of Medicine and the University of California, Riverside School of Medicine.
